Cells | Karyotype (major abnormalities) | IHC-positive | FISH-positive | aExpression of CD38 in CD19+ cells (%) | aSpecific cytotoxicity of anti-CD19-CAR T cells (%) | aSpecific cytotoxicity of anti-CD38-CAR T cells (%) |
---|---|---|---|---|---|---|
Patient 1 | t(8;22)(q24;q11.2),t(14;18)(q32;q21) | BCL2 MYC: ND | BCL2 MYC | 98.69 ± 0.37 | 92.67 ± 0.55 | 97.49 ± 0.19 |
Patient 2 | add(8)(q24),t(8;14)(q24;q32), t(3;22)(q27;q11.2) | BCL2 BCL6 MYC | BCL6 MYC | 98.74 ± 0.59 | 95.53 ± 2.88 | 99.88 ± 0.73 |
Patient 3 | ND | BCL2 BCL6 MYC | BCL6 | 97.37 ± 0.02 | 98.94 ± 0.03 | 99.60 ± 0.27 |
Patient 4 | ND | BCL2 MYC: ND | BCL2 MYC | 98.47 ± 0.26 | 98.26 ± 0.78 | 99.47 ± 0.04 |
Patient 5 | +8,add(3)(q27) | BCL2 BCL6 MYC | BCL6 | 97.14 ± 0.83 | 97.41 ± 0.16 | 97.70 ± 0.23 |